The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis (Q29542112)
scientific article (publication date: May 2003)
Language:
(P31) (Q13442814)
(Q30612)
(P50) (Q7792302)
(Q24067148)
(P304) 7-18
(P407) (Q1860)
(P433) 1
(P478) 61
(P577) +2003-05-00T00:00:00Z
(P921) (Q269829)
(Q170082)
(Q108483352)
(P1433) (Q7431607)
(P1476) "The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis" (language: en)
(P2093) D Perkins
J Addington
T.J Miller
S.W Woods
K.A Hawkins
R Hoffman
S Lindborg
M Tohen
A Breier
(P2860) (Q52042140)
(Q52100227)
(Q28258433)
(Q71570144)
(Q53360074)
(Q77349835)
(Q49038400)
(Q69249273)
(Q34330853)
(Q40001120)
(Q34372735)
(Q48578370)
(Q34302424)
(Q41671806)
(Q28301751)
(Q33933362)
(Q60644307)
(Q73140766)
(Q52016715)
(Q28288344)
(Q41091251)
(Q33745693)
(Q34108500)
(Q34322848)
(Q77587263)
(Q33788253)
(Q78033198)
(Q53458753)
(Q34508061)
(Q29614720)
(Q47234218)
(Q73671567)
(Q42550364)
(Q70662848)
(Q29619299)
(Q52007219)
(Q28288354)
(Q52070712)
other details
description scientific article (publication date: May 2003)

External Links